Quinsam Corporate Update
Toronto, Ontario--(Newsfile Corp. - July 12, 2021) - Quinsam Capital Corporation (CSE: QCA) ("Quinsam" or the "Company") wishes to announce an update on some of its investment holdings.
We have highlighted in the past that one of our investee companies, Agriforce Growing Systems Ltd. ("Agriforce"), was planning to undertake an IPO. We are pleased to say that the IPO has been completed and that Agriforce has commenced trading on the NASDAQ. Quinsam holds approximately 350,000 shares of Agriforce which were carried on our books at C$1.1 million as at March 31, 2021. The shares closed yesterday at US$5.60, putting the current value of our holding at almost US$2 million before any taxes payable on sales. We note that we have agreed to various escrow arrangements as part of the going public process.
"We are very pleased to see Agriforce complete its listing process," said Roger Dent, CEO of Quinsam. "Given that the marketing and closing of this offering occurred in very close proximity to the end of our second quarter, we will likely choose to carry this investment in Q2/2021 based on the $5 unit price at which the IPO was completed."
We are pleased to note that investee PMML, which operates the Rivalry e-sports betting platform, has closed its financing at US$0.58 per share and is now moving forward with plans to file a prospectus to facilitate its listing. The US$0.58 price implies an increase in value during Q2/2021 of approximately US$480,000 on our aggregate holding versus our March 31, 2021 carrying value.
Another investee, Pluribus, was planning to list in the current time frame but has deferred listing until the fall to facilitate an acquisition. Pluribus is currently marketing a new private financing at a premium of approximately 50% to our cost base. If completed, this will likely impact our Q3 carrying value.
We expect First Helium to commence trading in the week of July 11. We also expect Hempsana to commence trading in the week of July 11. Hempsana has recently raised additional funds at a solid premium to our Q1/2021 carrying value. Pathway Health completed its listing in June 2021 and we have made a modest profit to date. Green Impact listed a few weeks ago and is down marginally from our cost, which is surprising to us. We expect this company to do better as it finds a following. On the negative front, we anticipate that we will take a write-down on our Hemp Hydrate investment in the second quarter, although the positive moves in our portfolio during the quarter should more than offset this issue.
We also note that on July 9 the loan that we extended to Herbiculture to fund the construction of its Maryland dispensary was repaid in full. We continue to hold a right to a free 35% equity interest in the dispensary. We understand that the dispensary has been a strong performer to date.
We continue to look forward to a number of additional near term liquidity events, including those by by INX, Xebra, Green Stripe, Above Food and Budbank/Trees.
About Quinsam Capital Corporation
Quinsam is a merchant bank with a focus on "small cap" investments which it believes are undervalued. We do not invest on behalf of third parties or offer investment advice.
Generally, Quinsam does not believe that individual investments are material events. Quinsam may choose to announce certain investments once the company has finished buying its position because we feel that this information helps investors understand our decision making process. Generally, Quinsam does not announce sale of investments.
For further information contact:
Roger Dent, CEO
(647) 993-5475
roger@quinsamcapital.com